Stephanie Unwin has moved from chair to chief executive at Phylogica.

Phylogica chair becomes CEO

Perth business executive Stephanie Unwin is moving from chairman to chief executive of listed biotech company Phylogica, while one of its non-executive directors has been promoted to the role of chief scientific officer.

Phylogica announced today that Ms Unwin would fill the chief executive role left vacant when Richard Hopkins resigned in July last year.

Ms Unwin told Business News she expected to take up the new role in about two months, after serving out her notice period at current employer Synergy.


(existing subscribers)

The password field is case sensitive.
Request new password

Register for free

Sign up here for free access to 7 articles per month + twice daily business email alerts.

Thanks! This question prevents spammers...
Enter the characters shown in the image.

Add your comment

Phylogica (PYC)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/07/17

1 year TSR5 year TSR
thDreamscape Networks0%0%
41stePAT Technologies179%-25%
302ndBotanix Pharmaceuticals8%48%
710 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

$150k Sold
$840k Sold
$0 Other
Total value as at the date of the transaction
Source: Morningstar


195th-Botanix Pharmaceuticals$0
198th-Dreamscape Networks$0
199th-ePAT Technologies$0
230 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Phylogica

567thPaul Watt$269k
1475thBernard Hockings$44k
1652ndStephanie Unwin$26k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer